SOPHIRIS BIO INC. 4 SEC Filings

Filed On	Filing
23 Dec 2019	Form 4: Slover Peter T, Chief Financial Officer Granted 103,000 Common Stock (Right to Buy) ($37.1K)
23 Dec 2019	Form 4: Woods Randall E, Director Granted 175,000 Common Stock (Right to Buy) ($63K)
23 Dec 2019	Form 4: Hulme Allison, Director Granted 123,000 Common Stock (Right to Buy)
28 Jun 2019	Form 4: Proehl Gerald T, Director Granted 20,000 Stock Option (Right to Buy)
28 Jun 2019	Form 4: Heppell James L, Director Granted 20,000 Stock Option (Right to Buy)
28 Jun 2019	Form 4: Geltosky John, Director Granted 20,000 Stock Option (Right to Buy)
28 Jun 2019	Form 4: Ekman Lars, Director Granted 20,000 Stock Option (Right to Buy)
03 Jan 2019	Form 4: Slover Peter T, Chief Financial Officer Granted 205,667 Common Stock (Right to Buy)
03 Jan 2019	Form 4: Hulme Allison, Director Granted 245,000 Common Stock (Right to Buy)
03 Jan 2019	Form 4: Woods Randall E, Director Granted 335,000 Common Stock (Right to Buy)
20 Sep 2018	Form 4: Woods Randall E, Director Bought 10,000 shares ($26.3K)
28 Jun 2018	Form 4: Proehl Gerald T, Director Granted 20,000 Stock Option (Right to Buy)
28 Jun 2018	Form 4: Heppell James L, Director Granted 20,000 Stock Option (Right to Buy)
28 Jun 2018	Form 4: Geltosky John, Director Granted 20,000 Stock Option (Right to Buy)
28 Jun 2018	Form 4: Ekman Lars, Director Granted 20,000 Stock Option (Right to Buy)
08 Dec 2017	Form 4: Woods Randall E, Director Granted 107,995 Common Stock (Right to Buy)
08 Dec 2017	Form 4: Slover Peter T, Chief Financial Officer Granted 12,768 Common Stock (Right to Buy)
08 Dec 2017	Form 4: Hulme Allison, Director Granted 8,000 Common Stock (Right to Buy)
01 Jun 2017	Form 4: Proehl Gerald T, Director Granted 20,000 Stock Option (Right to Buy)
01 Jun 2017	Form 4: Heppell James L, Director Granted 20,000 Stock Option (Right to Buy)

Comments